Effect of High Dose Intravenous Vitamin C in Severe Pneumonia
Status:
Not yet recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
This trial is a multicenter, randomized, double-blind, two-arm, parallel-group,
placebo-controlled trial to investigate the effect of high dose intravenous (IV) Vitamin C as
an adjunct to the standard of care for patients with severe pneumonia versus placebo in ICU.